Joel Sendek insider trades

Open-market stock purchases and sales by Joel Sendek, Chief Financial Officer at Perspective Therapeutics, Inc, from SEC Form 4 filings since Nov 6, 2017.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -91%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • CATX Perspective Therapeutics, Inc: other filings, last Sep 4, 2025
  • SPRO Spero Therapeutics, Inc: 1 buy, 1 sale, last Jul 5, 2018

Get free alerts when Joel Sendek files a new trade →